NURABLAZE
Live / Registered — Registered (as of 18 Feb 2020)
What this means for you
Registered since 18 Feb 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88320074
- Registration number
- 5988021
- Mark type
- Stylized text
- Filed
- 28 Feb 2019
- Published for opposition
- 08 Oct 2019
- Registered
- 18 Feb 2020
- Attorney of record
- Andrew N. Spivak
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer
- Class 042 — Scientific and technological services: Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis services relating to the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of antibodies, and research and design relating thereto; industrial analysis and research services in the field of antibodies
Owner
- Y-mAbs Therapeutics, Inc, New York, NY, US
- Y-mAbs Therapeutics, Inc, New York, NY, US
- Y-mAbs Therapeutics, Inc, New York, NY, US
Prosecution history
- 18 Feb 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 18 Feb 2020 — REGISTERED-PRINCIPAL REGISTER
- 15 Jan 2020 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 05 Dec 2019 — NOTICE OF ALLOWANCE CANCELLED
- 15 Jan 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 Dec 2019 — TEAS DELETE 1(B) BASIS RECEIVED
- 03 Dec 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Oct 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Oct 2019 — PUBLISHED FOR OPPOSITION
- 18 Sept 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Sept 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Aug 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Aug 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Aug 2019 — ASSIGNED TO LIE
- 15 Aug 2019 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED